International Journal of Cancer: Research, Advances and Global Perspectives

International Journal of Cancer: A Guide for Researchers and Readers

The International Journal of Cancer (IJC) is a peer-reviewed scientific journal covering research into cancer. It publishes work from researchers and clinicians around the world, with the aim of sharing findings that can advance understanding, prevention, diagnosis and treatment of cancer.

What does the journal publish?

The journal covers a broad range of cancer research, including laboratory studies, clinical research and population-based investigations. Its subject areas include cancer biology, tumour development, genetics, epidemiology, prevention, diagnosis and treatment. This breadth makes it relevant to readers across disciplines, from basic scientists to healthcare professionals and public health researchers.

Articles may include original research and other scholarly contributions. As with any academic journal, the exact article types and submission requirements can change, so authors should consult the journal’s current guidance before preparing a manuscript.

Who is it for?

The journal’s international scope makes it a resource for researchers, clinicians, students and others interested in cancer research. Readers can use it to follow developments across different areas of oncology and to explore research produced in a range of countries and research settings.

For authors, publishing in a specialist cancer journal can help place research before an audience with relevant expertise. Choosing a journal is an important decision, however, and should involve considering the subject matter, readership, article requirements and publication policies.

Peer review and responsible reading

Peer review is intended to provide expert assessment of submitted research before publication. It is an important part of scholarly publishing, but it does not guarantee that a study is free from limitations or that its findings will apply to every patient or setting.

When reading an article, consider how the research was conducted, the size and characteristics of the study population, the limitations acknowledged by the authors and whether the conclusions are supported by the results. A single study should usually be considered alongside other evidence, rather than treated as definitive advice about cancer care.

Accessing articles and submitting research

Access to individual articles may depend on the publication model and the reader’s institution or subscription. Some content may be available through open-access arrangements. Authors should check the journal’s website for current information about access options, fees, copyright and licensing.

Researchers considering a submission should also review the journal’s latest instructions for authors, including its scope, formatting requirements, research ethics policies and data-sharing guidance. These details can change over time.

In summary

The International Journal of Cancer is a scholarly journal devoted to research across the cancer field. Its international coverage and range of subjects make it relevant to researchers and healthcare professionals seeking to engage with published cancer research. As with all scientific literature, its articles are best read critically and considered as part of the wider body of evidence.

 

International Journal of Cancer: A Comprehensive, Peer-Reviewed Resource for Global Cancer Research and Clinical Practice

1. Covers a broad range of cancer research.
2. Features research from around the world.
3. Uses peer review for submitted research.
4. Relevant to researchers and clinicians.
5. Includes work across laboratory and clinical fields.
6. Helps readers keep up with cancer research.
7. Offers authors a specialist scholarly audience.

 

Challenges of Engaging with the International Journal of Cancer: Accessibility, Technicality, and Practicality

1. Some articles may require a subscription.
2. Research can be highly technical.
3. Publication timelines may be lengthy.
4. Open-access fees may apply to some authors.
5. Findings may not translate directly into clinical practice.

Covers a broad range of cancer research.

A key advantage of the International Journal of Cancer is its broad coverage of cancer research, spanning areas such as cancer biology, genetics, prevention, diagnosis, treatment and epidemiology. This range allows readers from different disciplines to explore developments beyond their own specialisms and helps bring diverse perspectives together in one publication.

Features research from around the world.

A key advantage of the International Journal of Cancer is that it features research from around the world. This international perspective gives readers access to findings from diverse populations, healthcare systems and research settings, helping to broaden understanding of cancer and highlight questions that may be overlooked in studies focused on a single country or region.

Uses peer review for submitted research.

The International Journal of Cancer uses peer review to assess submitted research before publication. Specialist reviewers examine the work’s methods, evidence and conclusions, helping editors judge its quality and suitability for the journal. This process supports scholarly standards and gives readers greater confidence in published research, while it cannot guarantee that a study is free from limitations or errors.

Relevant to researchers and clinicians.

The International Journal of Cancer is relevant to both researchers and clinicians, bringing together findings from across cancer biology, epidemiology and clinical practice. Researchers can keep up with developments in the field, while clinicians can explore evidence that may inform their understanding of cancer prevention, diagnosis and treatment. Its wide-ranging coverage encourages knowledge-sharing between research and healthcare communities.

Includes work across laboratory and clinical fields.

One advantage of the International Journal of Cancer is its coverage of research across both laboratory and clinical fields. By bringing together studies on the biological mechanisms of cancer with research into diagnosis and treatment, the journal offers readers a broader view of the subject and encourages connections between scientific discovery and patient care.

Helps readers keep up with cancer research.

The International Journal of Cancer helps readers keep up with developments in cancer research by publishing studies from a wide range of fields, including cancer biology, prevention, diagnosis and treatment. Its international scope gives readers access to research and perspectives from across the world, making it a useful resource for following new findings and emerging trends.

Offers authors a specialist scholarly audience.

Publishing in the International Journal of Cancer offers authors access to a specialist scholarly audience with an established interest in cancer research. This can help place their findings before researchers and clinicians working in relevant areas, encourage informed discussion and make it easier for readers to connect new results with existing work in the field.

Some articles may require a subscription.

One drawback of the International Journal of Cancer is that some articles may require a subscription or payment to access. This can make it harder for independent researchers, students and readers without access through a university or library to consult the full research, limiting how widely important findings can be shared.

Research can be highly technical.

Research published in the International Journal of Cancer can be highly technical, using specialist terminology, complex methods and detailed statistical analysis. This may make some articles difficult to follow for readers without a background in cancer research or related scientific fields.

Publication timelines may be lengthy.

One potential drawback of the International Journal of Cancer is that publication timelines may be lengthy. Manuscripts can take time to move through editorial assessment, peer review and revision, which may delay the release of findings. Timings vary depending on the paper and review process, so authors should check the journal’s latest guidance and factor possible delays into their research and publication plans.

Open-access fees may apply to some authors.

One potential drawback of publishing in the International Journal of Cancer is that open-access fees may apply to some authors. These charges can be a significant expense, particularly for researchers without dedicated funding, and may affect their ability to make an article freely available to all readers. Authors should check the journal’s current fees and any available institutional agreements or funding support before submitting their work.

Findings may not translate directly into clinical practice.

A potential limitation of research published in the International Journal of Cancer is that findings may not translate directly into clinical practice. Laboratory studies and early-stage trials can offer valuable insights, but their results may not reflect the complexity of treating patients in real-world settings. Further research, including larger clinical trials and evaluation across diverse patient groups, is often needed before findings can inform routine care.